153 related articles for article (PubMed ID: 31397384)
21. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
[TBL] [Abstract][Full Text] [Related]
22. Screening Leishmania donovani complex-specific genes required for visceral disease.
Zhang WW; Matlashewski G
Methods Mol Biol; 2015; 1201():339-61. PubMed ID: 25388124
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of nucleoside transporter gene replacements in Leishmania donovani.
Liu W; Boitz JM; Galazka J; Arendt CS; Carter NS; Ullman B
Mol Biochem Parasitol; 2006 Dec; 150(2):300-7. PubMed ID: 17050001
[TBL] [Abstract][Full Text] [Related]
24. Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.
Al-Salabi MI; de Koning HP
Antimicrob Agents Chemother; 2005 Sep; 49(9):3682-9. PubMed ID: 16127040
[TBL] [Abstract][Full Text] [Related]
25. Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence.
Zhu Y; Davis A; Smith BJ; Curtis J; Handman E
Int J Parasitol; 2009 May; 39(6):713-23. PubMed ID: 19136005
[TBL] [Abstract][Full Text] [Related]
26. Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis.
Calvo-Álvarez E; Guerrero NA; Alvarez-Velilla R; Prada CF; Requena JM; Punzón C; Llamas MÁ; Arévalo FJ; Rivas L; Fresno M; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
PLoS Negl Trop Dis; 2012; 6(11):e1927. PubMed ID: 23209866
[TBL] [Abstract][Full Text] [Related]
27. ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.
Arcari T; Manzano JI; Gamarro F
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971869
[TBL] [Abstract][Full Text] [Related]
28. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
29. Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.
Manzano JI; Perea A; León-Guerrero D; Campos-Salinas J; Piacenza L; Castanys S; Gamarro F
Parasit Vectors; 2017 May; 10(1):267. PubMed ID: 28558770
[TBL] [Abstract][Full Text] [Related]
30. Intracellular Survival of Leishmania major Depends on Uptake and Degradation of Extracellular Matrix Glycosaminoglycans by Macrophages.
Naderer T; Heng J; Saunders EC; Kloehn J; Rupasinghe TW; Brown TJ; McConville MJ
PLoS Pathog; 2015 Sep; 11(9):e1005136. PubMed ID: 26334531
[TBL] [Abstract][Full Text] [Related]
31. FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis.
Carrara GMP; Stolf BS
Mem Inst Oswaldo Cruz; 2024; 119():e230182. PubMed ID: 38511814
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of nucleoside transporters in Leishmania and African trypanosomes.
Landfear SM
Biochem Pharmacol; 2001 Jul; 62(2):149-55. PubMed ID: 11389872
[TBL] [Abstract][Full Text] [Related]
33. Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition.
Mundodi V; Kucknoor AS; Gedamu L
BMC Mol Biol; 2005 Feb; 6():3. PubMed ID: 15691375
[TBL] [Abstract][Full Text] [Related]
34. Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite.
Cabello-Donayre M; Orrego LM; Herráez E; Vargas P; Martínez-García M; Campos-Salinas J; Pérez-Victoria I; Vicente B; Marín JJG; Pérez-Victoria JM
Cell Mol Life Sci; 2020 May; 77(9):1827-1845. PubMed ID: 31372684
[TBL] [Abstract][Full Text] [Related]
35. Loss of virulence in NAD(P)H cytochrome b5 oxidoreductase deficient Leishmania major.
Mukherjee A; Adhikari A; Das P; Biswas S; Mukherjee S; Adak S
Biochem Biophys Res Commun; 2018 Sep; 503(1):371-377. PubMed ID: 29906460
[TBL] [Abstract][Full Text] [Related]
36. Iron uptake controls the generation of Leishmania infective forms through regulation of ROS levels.
Mittra B; Cortez M; Haydock A; Ramasamy G; Myler PJ; Andrews NW
J Exp Med; 2013 Feb; 210(2):401-16. PubMed ID: 23382545
[TBL] [Abstract][Full Text] [Related]
37. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
38. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
39. Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity.
Vasudevan G; Ullman B; Landfear SM
Proc Natl Acad Sci U S A; 2001 May; 98(11):6092-7. PubMed ID: 11353834
[TBL] [Abstract][Full Text] [Related]
40. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.
Zhang WW; Matlashewski G
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8807-11. PubMed ID: 9238059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
